| Old Articles: <Older 511-520 Newer> |
|---|
 |
Chemistry World
April 23, 2013
Phillip Broadwith |
Ireland picks preferred drugs Ireland has become the first country to identify lists of 'preferred drugs'. Ensuring patients use the best value-for-money drugs could save patients and taxpayers millions of euros, says the Irish Health Service Executive.   |
Chemistry World
April 19, 2013
Phillip Broadwith |
Objections raised to GSK pay-for-delay deals The UK Office of Fair Trading has said that GlaxoSmithKline's deals to delay generic drugs infringed competition laws. |
Chemistry World
April 9, 2013
Emma Stoye |
Drug restrictions delay magic mushroom trial The first clinical trial to explore the antidepressant effects of psilocybin, the hallucinogenic component of magic mushrooms, has been delayed by EU and UK drug regulations. |
AskMen.com
April 8, 2013
Rebecca May |
Margaret Thatcher Dies You maybe not be sure what to think of the UK's first female prime minister, but Twitter, at least, is full of strong opinions on Margaret Thatcher. |
Chemistry World
April 4, 2013
Joe Connor |
An artful solution to scientist shortfall There has been much attention given recently to concerns regarding the overproduction of science graduates in the United Kingdom. |
Chemistry World
April 2, 2013
Laura Howes |
Funding boost for PhDs UK research funder, the Engineering and Physical Sciences Research Council, has announced 84.2 million for doctoral training grants, stipends awarded to institutions to fund PhD students. |
Chemistry World
April 2, 2013
Bibiana Campos Seijo |
More job cuts... The news came in that AstraZeneca is to invest 330 million pounds in a new strategic R&D center and global headquarters in Cambridge, UK. Unfortunately, there is also a negative angle to this story. |
Chemistry World
March 28, 2013
Emma Stoye |
London mayor accused over dust suppressants The European commission is investigating the use of dust suppressants in London following accusations that they were deliberately used around air monitoring sensors to disguise high levels of pollution. |
Chemistry World
March 21, 2013
Andy Extance |
Court convicts ex-Aptuit researcher over drug data Steven Eaton, a former employee at drug discovery and development firm Aptuit's Riccarton site in Scotland, produced flawed data over six years. |
Chemistry World
March 20, 2013
Laura Howes |
4.4m donation gives RI breathing room The Royal Institution has received a 4.4 million pound bailout that will allow the organization to remain in its iconic home in Albemarle Street in London, for now. |
| <Older 511-520 Newer> Return to current articles. |
